Skip to main content
. 2019 Dec 24;14:3003–3015. doi: 10.2147/COPD.S226783

Table 6.

Comparison of Clinical Outcomes of Quartile-Count of Eosinophil Cohorts

Variables Overall Absolute Count of Peripheral Blood Eosinophilf
Groups 1 2 3 4 P value
Participants, n 493 129 120 129 115
Stay of hospital, median (IQR) 11(9–14) 12(10–14) 10(8–14) 11(8–13) 10(9–13) 0.002
ICU admission, n (%) 6(1.2) 5(1) 0(0) 0(0) 1(0.2) 0.01
Mortality, n (%) 5(1) 1(0.2) 3(0.6) 1(0.2) 0(0) 0.283*
Comorbidity, n (%) Cardiovascular disease 371(75.3) 103(79.8) 91(75.8) 97(75.2) 80(69.6) 0.325
Ischemic heart disease 73(14.8) 15(11.6) 20(16.7) 19(14.7) 19(16.5) 0.663
Heart failure 188(38.1) 62(48.1) 52(43.3) 39(30.2) 35(30.4) 0.005
Hypertension 207(42) 50(38.8) 52(43.3) 57(44.2) 48(41.7) 0.824
Peripheral vascular disease 63(12.8) 18(14) 11 (9.2) 18 (14) 16(13.9) 0.613
Arrhythmia 78(15.8) 24(18.6) 18(15) 20(15.5) 16(13.9) 0.767
Diabetes 81(16.4) 20(15.5) 25(20.8) 21(16.3) 15 (13) 0.433
Bronchiectasis 87(17.6) 22(17.1) 24(20) 21(16.3) 20(17.4) 0.884
Respiratory failure 215(43.6) 72(55.8) 52(43.3) 48(37.2) 43(37.4) 0.008
Pulmonary heart disease 203(41.2) 67(51.9) 54(45) 44(34.1) 38(33) 0.005
Mechanical ventilation, n (%) NIMV 147(29.8) 53(41.1) 37(30.8) 28(21.7) 29(25.2) 0.005
IMV 4(0.8) 2(0.4) 1(0.2) 0(0) 1(0.2) 0.657*
Duration of NIMV 238(139.75–309.75) 237(138.5–320) 242.49(148.295)** 242.71(116.665)** 241(164.25–304.25) 0.994

Notes: fPatients were grouped by quartile absolute count (0, 0.05×109/L, 0.17×109/L) of blood eosinophils and divided into group 1, 2, 3 and 4 (from low to high).IQR, interquartile range: 25%–75%; *Fisher’s exact probability method; **Mean (SD, standard deviation).

Abbreviations: N, number; E%, percent of blood eosinophil in white blood cell; E, absolute count of peripheral blood eosinophil; ICU, intensive care unit; NIMV, noninvasive mechanical ventilation; IMV, invasive mechanical ventilation.